HYBRID EVENT: You can participate in person at Rome, Itlay or Virtually from your home or work.

11th Edition of International Conference on

Neurology and Neurological Disorders

June 05-07, 2025 | Rome, Italy

Neurology 2025

Fibromyalgia treated with transcranial Direct Current Stimulation (tDCS) and physical exercise

Speaker at Neurology and Neurological Disorders 2025 - Milton C R Medeiros
Irmandade Santa Casa de Arapongas PR, Brazil
Title : Fibromyalgia treated with transcranial Direct Current Stimulation (tDCS) and physical exercise

Abstract:

Introdution: fibromyalgia is a chronic and heterogeneous condition, characterized by diffuse musculoskeletal pain and associated changes, such as anxiety disorder, sleep disorder, depression, cognitive impairment and fatigue {1}. Fibromyalgia is a frequent cause of pain and affects about 2.5 to 3% of the world's population. It predominates in women and is an impacting factor in the worsening of quality of life, causing physical, emotional and financial damage [2]. The pain associated with fibromyalgia often is described as a constant dull ache that has lasted for at least three months. To be considered widespread, the pain must occur on both sides of body and above and below the waist [3]. Other condictions often co-exist with fibromyalgia, such as irritable bowel syndrome, migraine and other types of headaches, intersticial cystitis or painful blader, postural tachycardia syndrome and temporomandibular joint disorders syndrome. While there is no cure for fibromyalgia, a variety of treatment is avaliable. Fibromyalgia treatment involves various methods, such as physical activity, cognitive behavioral therapy, and medications. Unfortunately, these approaches do not offer satisfactory results for most patients. Medications, for example, have low efficacy and significant risks of side effects. The most commonly used drugs are tricyclic antidepressants such as amitriptyline, dual antidepressants such as duloxetine, and antiepileptics such as gabapentin and pregabalin [4]. Although there is no clear understanding of the disease’s etiology, the consensus on its pathogenesis is dysfunction in the central processing of pain perception and control systems that result in a state of increased sensitization to pain and Other stimuli [5]. Neuromodulation, especially transcranial direct current stimulation (tDCS), has been shown to have a significant impact on pain relief and functional improvement of fibromyalgia patients in many studies [6]. The tDCS is a neuromodulation method based on cortical modulation, producing facilitating or inhibitory effects in several brain areas. Popularity of the technique has grown over the past decade, as exemplified in a PubMed search, returning 1,500 published articles containing the phrase “tDCS” between 2011 and 2015, in comparison to just 65 articles published between 2000 and 2005. The tDCS involves the emission of a weak electrical current, traditionally via the placement of two electrodes, one anodal that facilitates neuronal depolarization and another cathodal that hinders neuronal depolarization [7]. The tDCS  may offer a new line of treatment for fibromyalgia [8]. Another important modality for treating fibromyalgia is physical activity. International treatment recommendations for fibromyalgia highlight the importance of  physical activity  combined with patient education [9].In this research, we will demonstrate the results of tDCS alone and tDCS plus physical activity in the treatment of fibromyalgia.

Materials and Methods: Ten outpatients, all women, with fibromyalgia, participated in the study. All signed the informed consent form after detailed explanations about the method. They used different medications for fibromyalgia (anticonvulsants, dual antidepressants, tricyclic antidepressants and muscle relaxants) alone or in different combinations. All had intense pain, with a visual analogue scale (VAS) of 8 or more. These women were sedentary or did very little physical activity (less than once a week). The medications were maintained, and they were randomized into two groups matched by age. In group 1, five patients, with a mean age of 44.4 years old, received tDCS two milliamps for 20 minutes from Monday to Friday, for four weeks, with the anodal pole in the left motor area (M1) and the supraorbital cathodal pole on the right, without practicing physical activity. In group 2, Five patients, with a mean age of 43,2 years old, received the same tDCS stimulus, but with physical activity (walking) of 150 minutes per week divided into 3 or more times. The VAS was reassessed after 4 weeks of treatment.

Results: The patients, all with severe pain before the procedure (average of 8.5 on the VAS), were evaluated before the start of tDCS and after 4 weeks, on the last day of tDCS. All patients completed the study. Patients in group 1 (tDCS without physical activity) had the following VAS values after 4 weeks: 4, 3, 4, 5, and 3. VAS average of 3.8. Therefore, there was a significant reduction in pain intensity just by applying tDCS. In group 2 (tDCS associated with physical activity), the results were even better, with VAS after 4 weeks of 1, 2, 2,1 and 2. VAS average of 1,6. The differences between group 1 (tDCS without physical activity) and group 2 (tDCS associated with physical activity) were statistically significant, with t (t student) of -4.91 and calculation of p showing very small number. There were no reports of significant side effects. In general, there were discrete paresthetic sensations of short duration at the site of electrical stimulation.

Discussion: In this small randomized sample, it was possible to observe significant pain relief in patients with fibromyalgia. Studies have shown that the anodal stimulus in the primary motor area should be the one of choice for the improvement of pain sensations [10]. The procedure is cheap, safe and very well tolerated by patients, showing itself as a promising therapeutic technique for chronic pain in patients with fibromyalgia. In this study, the symptoms that accompany pain in fibromyalgia, such as sleep disturbances, fatigue, memory disorders, depression, or anxiety, were not evaluated. But, there are studies showing that pain is not the only symptom to improve in fibromyalgia, and there is an improvement in quality of life with the use of tDCS [11]. Regarding physical activity, several studies show its effectiveness for pain relief in fibromyalgia [12]. In our study, it was very evident that the association of tDCS with physical activity was much more effective than tDCS alone.

Conclusion: tDCS is a very promising method for the treatment of fibromyalgia, mainly due to its safety, low cost, and possible good efficacy Our study suggests that the association of physical activity with tDCS intensifies pain improvement, when compared to tDCS alone. Studies with a larger number of patients should be carried out for more robust conclusions

Biography:

Dr. Milton C. R. Medeiros is a titular member of the Brazilian Academy of Neurology. Graduated in medicine from the State University of Londrina in 1994 (UEL). Medical residency in neurology at UEL, graduated as specialist in 1997. Member of the Brazilian Academy of Neurology since 2002. Member of the headache and pain scientific departments at the Brazilian Academy of Neurology. He is also a member of the scientific department of the cognitive neurology and aging. Dr. Milton is a writer. His latest book is "Fuja do Alzheimer agora mesmo", publisher Viseu, still an exclusive edition in Portuguese.

Watsapp